Effects of cycloheximide on chromatin-bound and -unbound PCNA in HeLa cells

Oncology. 1995 Sep-Oct;52(5):419-21. doi: 10.1159/000227500.

Abstract

We examined the effects of cycloheximide on the amount of chromatin-bound and -unbound PCNA subpopulations in HeLa cells. The chromatin-bound PCNA content decreased rapidly in the presence of cycloheximide, whereas the reduction of the total amount of PCNA was minimal even 24 h after the treatment with cycloheximide. From these data, the half-life of PCNA was estimated to be 31.0 h for chromatin-bound PCNA and 276.8 h for the total.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromatin / metabolism*
  • Cycloheximide / pharmacology*
  • Half-Life
  • HeLa Cells / drug effects
  • HeLa Cells / immunology*
  • Humans
  • Proliferating Cell Nuclear Antigen / drug effects*
  • Proliferating Cell Nuclear Antigen / metabolism

Substances

  • Chromatin
  • Proliferating Cell Nuclear Antigen
  • Cycloheximide